Los Angeles Capital Management LLC Ocular Therapeutix, Inc Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$3.01 - $5.22 $223,655 - $387,866	-74,304 Reduced 21.21%	275,984 $1.11 Million
Q1 2022 May 06, 2022	BUY	$4.83 - $7.35 $1.69 Million - $2.57 Million	350,288 New	350,288 $1.73 Million
Q2 2021 Aug 05, 2021	SELL	$13.43 - $19.16 $178,417 - $254,540	-13,285 Closed	0 $0
Q1 2021 May 05, 2021	SELL	$15.82 - $22.11 $1,977 - $2,763	-125 Reduced 0.93%	13,285 $218,000
Q4 2020 Feb 04, 2021	BUY	$7.91 - $22.95 $106,073 - $307,759	13,410 New	13,410 $278,000

151

136M

86.4K

263K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $668M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.